Tamoxifen and the Rafoxifene analog LY117018: Their effects on arachidonic acid release from cells in culture and on prostaglandin I2 production by rat liver cells

BMC Cancer

Volumn 4, Issue , 2004, Pages

  Levine, Lawrence ^a  

^a BRANDEIS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 HYDROXY 2 (4 HYDROXYPHENYL) 3 [4 [2 (1 PYRROLIDINYL)ETHOXY]BENZOYL]BENZO[B]THIOPHENE; ARACHIDONIC ACID; DACTINOMYCIN; ESTROGEN; FULVESTRANT; LACTACYSTIN; PHORBOL 13 ACETATE 12 MYRISTATE; PHOSPHOLIPASE; PROSTACYCLIN; RALOXIFENE; TAMOXIFEN; TRITIUM; ANTIESTROGEN; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; CYCLOOXYGENASE 2; ESTROGEN RECEPTOR; ISOENZYME; MEMBRANE PROTEIN; PROSTAGLANDIN SYNTHASE; PTGS2 PROTEIN, HUMAN; PYRROLIDINE DERIVATIVE; THIOPHENE DERIVATIVE;

ANIMAL CELL; ARTICLE; BREAST CANCER; BREAST CARCINOMA; CANCER CELL CULTURE; CANCER GROWTH; CANCER PREVENTION; CELL CULTURE; CELL LABELING; COLON CARCINOMA; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; ENZYME ACTIVITY; GLIA CELL; GROWTH INHIBITION; HUMAN; HUMAN CELL; INCUBATION TIME; LIVER CELL; NONHUMAN; OXYGENATION; PROSTAGLANDIN SYNTHESIS; QUANTITATIVE ANALYSIS; RAT; ANIMAL; BIOSYNTHESIS; BREAST TUMOR; COLON TUMOR; DRUG ANTAGONISM; LIVER; METABOLISM; SECRETION (PROCESS); TUMOR CELL CULTURE;

ANIMALS; ANTINEOPLASTIC AGENTS, HORMONAL; ARACHIDONIC ACID; BREAST NEOPLASMS; COLONIC NEOPLASMS; CYCLOOXYGENASE 2; EPOPROSTENOL; ESTROGEN ANTAGONISTS; HUMANS; ISOENZYMES; LIVER; MEMBRANE PROTEINS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PYRROLIDINES; RATS; RECEPTORS, ESTROGEN; TAMOXIFEN; THIOPHENES; TUMOR CELLS, CULTURED;

EID: 12944303752     PISSN: 14712407     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2407-4-49     Document Type: Article

References (31)

1. MacGregor JL, Jordan VC: Basic guide to the mechanisms of antiestrogen action. Pharmacol Rev 1998, 50:151-196.
2. Jordan VC, Morrow M: Tamoxifen, raloxifene, and the prevention of breast cancer. Endocr Rev 1999, 20:253-278.
3. Gottardis MM, Jordan VC: Antitumor actions of keoxifene and tamoxifen in the N-nitrosomethylurea-induced rat mammary carcinoma model. Cancer Res 1987, 47:4020-4024.
4. Levine L: Tamoxifen stimulates arachidonic acid release from rat liver cells by an estrogen receptor-independent, nongenomic mechanism.b] BMC Cancer 2003, 3:24.
5. Levine L: Stimulated release of arachidonic acid from rat liver cells by celecoxib and indomethacin. Prostaglandins Leukot Essent Fatty Acids 2001, 65:31-35.
6. Hong SL, Levine L: Inhibition of arachidonic acid release from cells as the biochemical action of anti-inflammatory corticosteroids. Proc Natl Acad Sci U S A 1976, 73: 730-1734.
7. Pong SS, Hong SL, Levine L: Prostaglandin production by methylcholanthrene-transformed mouse BALB/3T3. Requirement for protein synthesis. J Biol Chem 1977, 252:1408-1413.
8. Levine L, Alam I: Deacylation of cellular lipids and arachidonic acid metabolism. Prog Lipid Res 1981, 20: 1-88.
9. Chan TA, Morin PJ, Vogelstein B, Kinzler KW: Mechanisms underlying nonsteroidal antiinflammatory drug-mediated apoptosis. Proc Natl Acad Sci U S A 1998, 95:681-686.
10. Levine L: Measurement of arachidonic acid metabolites by radioimmunoassay. Manual of Clinical Laboratory Immunology. Washington DC: American Society for Microbiology 31986:685-691.
11. Gelmann EP: Tamoxifen induction of apoptosis in estrogen receptor-negative cancers: new tricks for an old dog? J Natl Cancer Inst 1996, 88:224-226.
12. Mandlekar S, Yu R, Tan TH, Kong AN: Activation of caspase-3 and c-Jun NH2-terminal kinase-1 signaling pathways in tamoxifen-induced apoptosis of human breast cancer cells. Cancer Res 2000, 60:5995-6000.
13. Dietze EC, Caldwell LE, Grupin SL, Mancini M, Seewaldt VL: Tamoxifen but not 4-hydroxytamoxifen initiates apoptosis in p53(-) normal human mammary epithelial cells by inducing mitochondrial depolarization. J Biol Chem 2001, 276:5384-5394.
14. Robertson DW, Katzenellenbogen JA, Long DJ, Rorke EA, Katzenellenbogen BS: Tamoxifen antiestrogens. A comparison of the activity, pharmacokinetics, and metabolic activation of the cis and trans isomers of tamoxifen. J Steroid Biochem 1982, 16:1-13.
15. Hollstein M, Sidransky D, Vogelstein B, Harris CC: p53 mutations in human cancers. Science 1991, 253:49-53.
16. Rockwell P, Yuan H, Magnusson R, Figueiredo-Pereira ME: Proteasome inhibition in neuronal cells induces a proinflammatory response manifested by upregulation of cyclooxygenase-2, its accumulation as ubiquitin conjugates, and production of the prostaglandin PGE(2). Arch Biochem Biophys 2000, 374:325-333.
17. Vane JR, Bakhle YS, Botting RM: Cyclooxygenases 1 and 2. Annu Rev Pharmacol Toxicol 1998, 38:97-120.
18. Wakeling AE: Use of pure antioestrogens to elucidate the mode of action of oestrogens. Biochem Pharmacol 1995, 49: 545-1549.
19. Levine L: Stimulated release of arachidonic acid by agonists of the peroxisome proliferator-activated receptor and retinoic acid receptors. Prostaglandins Leukot Essent Fatty Acids 2001, 65:229-232.
20. Mokbel K: The evolving role of aromatase inhibitors in breast cancer. Int J Clin Oncol 2002, 7:279-283.
21. Whatley RE, Satoh K, Zimmerman GA, McIntyre TM, Prescott SM: Proliferation-dependent changes in release of arachidonic acid from endothelial cells. J Clin Invest 1994, 94:1889-1900.
22. Whiting KP, Restall CJ, Brain PF: Steroid hormone-induced effects on membrane fluidity and their potential roles in non-genomic mechanisms. Life Sci 2000, 67:743-757.
23. Levine L: Does the release of arachidonic acid from cells play a role in cancer chemoprevention? FASEB J 2003, 17: 00-802.
24. Levine L: Lactacystin stimulates arachidonic acid metabolism in rat liver cells: effects of cell density on arachidonic acid release, PGI2 production and cyclooxygenase activity. Prostaglandins Leukot Essent Fatty Acids 2000, 63:371-375.
25. Croxtall JD, Choudhury Q, White JO, Flower RJ: Tamoxifen inhibits the release of arachidonic acid stimulated by thapsigargin in estrogen receptor-negative A549 cells. Biochim Biophys Acta 1997, 1349:275-284.
26. Zhang W, Couldwell WT, Song H, Takano T, Lin JH, Nedergaard M: Tamoxifen-induced enhancement of calcium signaling in glioma and MCF-7 breast cancer cells. Cancer Res 2000, 60:5395-5400.
27. Peyrade F, Frenay M, Etienne MC, Ruch F, Guillemare C, Francois E, Namer M, Ferrero JM, Milano G: Age-related difference in tamoxifen disposition. Clin Pharmacol Ther 1996, 59: 01-410.
28. Smith WL: The eicosanoids and their biochemical mechanisms of action. Biochem J 1989, 259:315-324.
29. Jourdan KB, Evans TW, Goldstraw P, Mitchell JA: Isoprostanes and PGE2 production in human isolated pulmonary artery smooth muscle cells: concomitant and differential release. FASEB J 1999, 13:1025-1030.
30. Brash AR: Lipoxygenases: occurrence, functions, catalysis, and acquisition of substrate. J Biol Chem 1999, 274: 3679-23682.
31. Capdevila JH, Falck JR: The CYP P450 arachidonic acid monooxygenases: from cell signaling to blood pressure regulation. Biochem Biophys Res Commun 2001, 285:571-576.